---
title: "Rasha Al-Lamee"
date: "2024-08-21T09:27:45.000Z"
publishedDate: "21 août 2024"
summary: "Best known for her work as the principal investigator in the ORBITA trial—a placebo-controlled trial showing that stenting did not improve exercise tolerance or chest pain any more than a sham procedure—Rasha Al-Lamee (Imperial College London, London, UK) talks to Cardiovascular News about the history of the trial and how it has influenced a series [&#8230;] The post Rasha Al-Lamee appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/rasha-al-lamee/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-08-21-rasha-al-lamee"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/08/Dr-Rasha-Al-Lamee-fin--1024x931.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/rasha-al-lamee/"
---

![Rasha Al-Lamee](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/08/Dr-Rasha-Al-Lamee-fin--1024x931.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/rasha-al-lamee/*

## L’essentiel

Best known for her work as the principal investigator in the ORBITA trial—a placebo-controlled trial showing that stenting did not improve exercise tolerance or chest pain any more than a sham procedure—Rasha Al-Lamee (Imperial College London, London, UK) talks to Cardiovascular News about the history of the trial and how it has influenced a series [&#8230;] The post Rasha Al-Lamee appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/rasha-al-lamee/
